- Home
- ESQ vs PHAR Comparison
ESQ vs PHAR Comparison
Compare ESQ & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESQ
- PHAR
- Stock Information
- Founded
- ESQ 2006
- PHAR 1988
- Country
- ESQ United States
- PHAR Netherlands
- Employees
- ESQ N/A
- PHAR N/A
- Industry
- ESQ Commercial Banks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- ESQ Finance
- PHAR Health Care
- Exchange
- ESQ Nasdaq
- PHAR Nasdaq
- Market Cap
- ESQ 638.2M
- PHAR 627.5M
- IPO Year
- ESQ 2017
- PHAR N/A
- Fundamental
- Price
- ESQ $78.87
- PHAR $9.37
- Analyst Decision
- ESQ Buy
- PHAR Strong Buy
- Analyst Count
- ESQ 4
- PHAR 3
- Target Price
- ESQ $70.00
- PHAR $27.00
- AVG Volume (30 Days)
- ESQ 61.8K
- PHAR 7.2K
- Earning Date
- ESQ 01-23-2025
- PHAR 10-24-2024
- Dividend Yield
- ESQ 0.76%
- PHAR N/A
- EPS Growth
- ESQ 2.35
- PHAR N/A
- EPS
- ESQ 4.95
- PHAR N/A
- Revenue
- ESQ $116,205,000.00
- PHAR $285,745,000.00
- Revenue This Year
- ESQ N/A
- PHAR $20.08
- Revenue Next Year
- ESQ $11.52
- PHAR $9.22
- P/E Ratio
- ESQ $15.84
- PHAR N/A
- Revenue Growth
- ESQ 10.32
- PHAR 30.64
- 52 Week Low
- ESQ $44.45
- PHAR $6.65
- 52 Week High
- ESQ $82.56
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- ESQ 52.39
- PHAR 50.02
- Support Level
- ESQ $76.97
- PHAR $9.56
- Resistance Level
- ESQ $82.56
- PHAR $10.15
- Average True Range (ATR)
- ESQ 2.31
- PHAR 0.60
- MACD
- ESQ -0.27
- PHAR -0.10
- Stochastic Oscillator
- ESQ 34.05
- PHAR 15.84
About ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.